title: Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib.
authors.forename: George A
authors.initials: GA
authors.lastname: Follows
authors.forename: Hannah
authors.initials: H
authors.lastname: Sims
authors.forename: David M
authors.initials: DM
authors.lastname: Bloxham
authors.forename: Thorsten
authors.initials: T
authors.lastname: Zenz
authors.forename: Melanie A
authors.initials: MA
authors.lastname: Hopper
authors.forename: Hongxiang
authors.initials: H
authors.lastname: Liu
authors.forename: Anthony
authors.initials: A
authors.lastname: Bench
authors.forename: Penny
authors.initials: P
authors.lastname: Wright
authors.forename: Mars B
authors.initials: MB
authors.lastname: Van't Veer
authors.forename: Mike A
authors.initials: MA
authors.lastname: Scott
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D013449:Sulfonamides / Q000008:administration & dosage*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf